Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

May 31, 2013

Conditions
Autism Spectrum DisordersHyperactivity
Interventions
DRUG

Omega-3 Fatty Acids

Omega-3 fatty acids will be delivered in orange-flavored pudding packets (Coromega®, Vista, CA). Each packet contains 650 mg of omega-3 fatty acids, 350mg of eicosapentanoic acid (EPA), 230mg of docosahexanoic acid (DHA) and 2,000 mg of fish oil 18/12, and will be given twice daily for a daily dose of 1.3 grams of omega-3 fatty acids (and 1.1 grams of DHA + EPA).

OTHER

Placebo

Placebo packets will have same orange-flavored pudding as active Omega-3 fatty acids comparator with an identical appearance and taste, but will include safflower oil instead of the fish oil. One placebo packet will be given twice daily.

Trial Locations (1)

21205

This study is open to continental USA, Multiple Locations

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter